Becklar and Actuate Honored with 2025 Technology Marvel Award
July 29, 2025 - 02:34
In a significant recognition of excellence in the monitoring center industry, Becklar and Actuate have been jointly awarded the prestigious Technology Marvel Award by The Monitoring Association and SSI. This accolade celebrates their innovative contributions to monitoring technology, which have set new standards in the field.
The award highlights the remarkable advancements made by both companies in enhancing operational efficiency and improving service delivery in monitoring centers. Their collaborative efforts have resulted in the development of state-of-the-art tools and systems that streamline processes and elevate the overall customer experience.
Becklar and Actuate's commitment to pushing the boundaries of technology has not only benefited their operations but has also contributed to the broader industry landscape. This recognition serves as a testament to their dedication to innovation and excellence in the monitoring sector. As the industry continues to evolve, the achievements of Becklar and Actuate will undoubtedly inspire future advancements in monitoring technology.
MORE NEWS
March 2, 2026 - 07:46
Canon: "New Technology" Compact Model is ComingPhotography enthusiasts and industry watchers are abuzz as Canon has released tantalizing hints about a new compact camera model currently in development. While full specifications and an official...
March 1, 2026 - 18:53
Digital Frontiers Reshape Montana's LandscapeThe spirit of innovation that once rode the rails into Montana is finding new expression in the digital age. Across the state, from sprawling ranches to remote mountain towns, modern technology is...
March 1, 2026 - 04:37
Silicon Valley Rallies Behind Anthropic in A.I. Clash With TrumpA significant rift appears to be widening between the federal government and the American technology sector, as industry leaders and workers rally behind artificial intelligence startup Anthropic....
February 28, 2026 - 04:58
Rare Disease Day: Revolutionising clinical trial enrolment and retention with technologyOn Rare Disease Day, the focus sharpens on the unique challenges of developing treatments for conditions affecting small, often geographically dispersed patient populations. A key industry expert...